Gene: YBX3
Official Full Name: Y-box binding protein 3provided by HGNC
Gene Summary: Enables RNA binding activity. Involved in cellular hyperosmotic response; cellular response to tumor necrosis factor; and negative regulation of programmed cell death. Located in cytosol. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO03295 | YBX3 Knockout cell line (HeLa) | Human | YBX3 | 1:3~1:6 | Negative | Online Inquiry |
KO03296 | YBX3 Knockout cell line (HCT 116) | Human | YBX3 | 1:2~1:4 | Negative | Online Inquiry |
KO03297 | YBX3 Knockout cell line (HEK293) | Human | YBX3 | 1:3~1:6 | Negative | Online Inquiry |
KO03298 | YBX3 Knockout cell line (A549) | Human | YBX3 | 1:3~1:4 | Negative | Online Inquiry |
YBX3 Gene Knockout Cell Lines are specially engineered cellular models designed to facilitate the study of the YBX3 gene, which plays a critical role in various biological processes, including gene regulation, cell proliferation, and stress response. These knockout cell lines are generated through the application of CRISPR-Cas9 genome editing technology, which enables precise disruptions of the YBX3 gene, allowing researchers to observe the resulting phenotypic and biochemical changes in the absence of its function.
The primary mechanism of these cell lines involves the complete loss-of-function of YBX3, providing an ideal platform to investigate its cellular roles and associated signaling pathways. By creating these knockout models, researchers can delve into the contributions of YBX3 to critical biological processes, including its implications in tumorigenesis, RNA binding, and transcriptional regulation.
In both fundamental research and clinical settings, YBX3 Gene Knockout Cell Lines serve as vital tools for elucidating the gene's involvement in diseases, particularly cancer, where YBX3 has been found to regulate critical oncogenic processes. As a key element in drug discovery and target validation, these cell lines enable researchers to explore potential therapeutic interventions and enhance understanding of the molecular underpinnings of various diseases.
One of the significant advantages of YBX3 Gene Knockout Cell Lines is their accessibility and ease of use, compared to traditional knockout strategies that may be time-consuming and technically challenging. Our cell lines are ready-to-use, allowing for rapid experimental setup and reproducibility, thus saving valuable time and resources for researchers.
The ability to manipulate specific genes and observe immediate outcomes significantly benefits researchers and clinicians engaged in both basic and translational research. This product not only enriches the existing toolkit for studying gene function but also positions laboratories to advance their investigations into gene-targeted therapies.
Our company specializes in providing high-quality biological models and tools tailored for cutting-edge research. With a commitment to innovation and scientific excellence, we ensure that our YBX3 Gene Knockout Cell Lines meet the highest standards, enabling researchers to achieve their scientific goals effectively.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.